GBA1 and Parkinson disease: In this study, we measured GCase substrates, GluSph and GluCer, as well as the product, ceramide, and additional lipids (galactosyl ceramide, galactosyl sphingosine, and glucosyl cholesterol) as negative controls in a cohort of GBA1 N370S mutation carriers and noncarriers with and without PD.